In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.
In this podcast, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the current guidelines for left main PCI, the techniques they use to position and optimise left main ostial stents, and intracoronary imaging to assist stent placement in the left main artery. They also discuss recent research into left main PCI, including the conflicting results of the EBC Main and DK Crush V trials. Dr AlMoghairi then outlines his thoughts towards mechanical circulatory support in left main stenting. Finally, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the gaps in knowledge and opportunities for future research, including operator training and geographic differences in left main PCI.
What are the latest developments in left main percutaneous coronary intervention? Where are the knowledge gaps?
Prefer to watch in video format? Click here.
If you have any questions or suggestions, please email managingeditor@ecrjournal.com.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
Join renowned experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they preview the most impactful late-breaking studies poised to make waves at this year’s AHA Conference.
